Table 3 Multivariate analysis of patient characteristics predicting survival.

From: Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan

 

Odds ratio

95% confidence interval

p-value

Age

0.919

0.87‒0.97

0.03

BMI

1.210

1.05‒1.40

0.01

Smoking experience

0.321

0.10‒1.03

0.057

Severity Ⅲ, Ⅳ

0.440

0.12‒1.66

0.23

mMRC 2‒4

1.980

0.56‒6.98

0.29

Resting SpO2 < 95% a

0.225

0.06‒0.85

0.03

LTOT

1.610

0.38‒6.88

0.52

Serum ALB

0.745

0.18‒3.12

0.69

Serum LDH

0.993

0.98‒1.00

0.17

Serum CRP

1.170

0.61‒2.25

0.64

%FVC

1.040

0.99‒1.08

0.06

  1. %FVC, % forced vital capacity; ALB, albumin; BMI, body mass index; CRP, C-reactive protein; LDH, lactate dehydrogenase; LTOT, long-term oxygen therapy; mMRC, modified Medical Research Council; SpO₂, saturation of arterial oxygen. a Those who could not measure their resting SpO2 with room air due to oxygen administration were included in resting SpO2 < 95%.
Back to article page